Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

As schools open, US ramps up COVID-19 testing, says GlobalData

Following the National Institute of Health’s (NIH) awarding of over $100m to increase COVID-19 testing; James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the current approach to reopening schools in the US: “As the US passes six million COVID-19 cases, while its citizens move relatively freely, it […]
Read more

Increasing use in home care settings to drive pulse oximeters growth in India, says GlobalData

The necessity to monitor the blood oxygen levels of asymptomatic and mildly symptomatic COVID-19 patients undergoing home isolation and proactive use by the common public in home care-settings are driving the demand for pulse oximeters in India, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘Pulse Oximeter Systems (Anesthesia and Respiratory Devices) – […]
Read more

Convalescent plasma EUA an important step towards COVID-19 treatment, says GlobalData

Following news that the United States Health and Human Services (HHS) received emergency use authorisation (EUA) from the Food and Drug Administration (FDA) for treating COVID-19 patients using convalescent plasma; Brian Hicks, Medical Analyst at GlobalData, a leading data and analytics company, offers his view: “This authorization comes at a time when currently existing COVID-19 […]
Read more

Abbott’s FDA approval for ICD and CRT-D places company in advantageous position over competitors

Abbott won FDA approval in July for its next-generation Gallant implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, which was equipped with Bluetooth technology and an accompanying smartphone app. This approval places Abbott in an advantageous position over other devices and may allow the company to recover faster from the impact of the […]
Read more

Changes to coverage policies for ventricular assist devices will impact heart failure device market, says GlobalData

The Centers for Medicare & Medicaid Services (CMS) in the US has issued a statement indicating their proposal to increase access to ventricular access devices (VADs) for patients living with severe heart conditions, including a specific update to the criteria for treatment with a Total Artificial Heart (TAH). Leading data and analystics company GlobalData expects […]
Read more

Thermo Fisher’s failed Qiagen acquisition will not significantly affect its future growth

Following the collapse of Thermo Fisher Scientific’s $11.5bn takeover of Qiagen; Brian Hicks, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “As one of the largest acquisitions in the MedTech industry to have potentially occurred in 2020, a successful deal would have propelled Thermo Fisher’s market capitalization by nearly 7%, […]
Read more

Wearable tech market set to grow 137% by 2024 but smartwatches to see a 10% decline in revenue this year due to shipment delays and tighter consumer wallets, says GlobalData

Wearables have seen significant growth in the medical market over the past several years due to their potential to address spiraling healthcare costs, aging populations, and the burden of chronic disease. According to GlobalData, the wearable tech market was worth nearly $27bn in 2019 and is likely to grow to $64bn by 2024 due to […]
Read more

Guardant Health expected to see continued revenue as EGFR test a much-needed boon for NSCLC space, says GlobalData

Following the FDA’s approval of Guardant Health’s liquid biopsy comprehensive tumor mutation profiling across all solid cancers; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “This is a landmark approval for cancer testing as Guardant Health’s liquid biopsy is the first of its kind to genetically profile […]
Read more

ResMed benefits from rising ventilator market, which sees forecast upwards adjustment of $3.8bn, says GlobalData

Following ResMed’s fiscal fourth quarter revenue report: Kamilla Kan, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “ResMed’s year-over-year increase of 9% in revenue is largely due to the increase in sales and production of ventilators due to COVID-19. COVID-19 has had a profound effect […]
Read more

COVID-19 pandemic severely impacting US reversible contraceptive devices market with 28.9% lost revenue expected in 2020, says GlobalData

Nearly 30% of revenue from reversible contraceptive devices in the US will be lost in 2020 due to COVID-19, as many procedures have been postponed and clinics have been closed. In comparison, developing countries are expected to experience a less severe decline, as governments have previously dealt with providing reproductive health during pandemics such as […]
Read more

FDA multiple-function device products update particularly affects telehealth, says GlobalData

Following Food and Drug Administration (FDA) announcement that guidelines on multiple-function devices were finalized; Kamilla Kan, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view on the recent news: “In its latest guidance update, the FDA’s advise that manufacturers should review whether the other functions of a medical device impact […]
Read more
1 … 39 40 41 42 43 … 50